Since its discovery in 1984 by Svetlana Mosjov, GLP-1 and its analogs (such as semaglutide, liraglutide, and dulaglutide) have rapidly become cornerstone treatments for type 2 diabetes mellitus (T2DM) and obesity
A 2008 study published in the Journal of Medicinal Chemistry demonstrated metabolic effects in rodent models at 50mg/kg, which led early researchers to extrapolate human-equivalent doses between 50100mg daily
Its ideal for budget travelers who dont want to miss the adventure
in the writing of the manuscript, or in the decision to publish the results
A 2025 nutrition review on GLP-1-based therapies highlights practical nutrition priorities during GLP-1 treatment, including attention to protein, fiber, hydration, and overall diet quality
Cognitive impairment in patients with fibromyalgia syndrome as assessed by the mini-mental state examination